Needham analyst Serge Belanger maintained a Buy rating on Verrica Pharmaceuticals (VRCA – Research Report) today and set a price
Category: Healthcare
Analysts Offer Insights on Healthcare Companies: and Exelixis (NASDAQ: EXEL)
There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Exelixis
Needham Keeps a Buy Rating on OncoCyte (OCX)
In a report released today, Michael Matson from Needham reiterated a Buy rating on OncoCyte (OCX – Research Report), with
Synlogic (SYBX) Received its Third Buy in a Row
After H.C. Wainwright and Piper Sandler gave Synlogic (NASDAQ: SYBX) a Buy rating last month, the company received another Buy,
Brookline Capital Markets Thinks Syros Pharmaceuticals’ Stock is Going to Recover
Brookline Capital Markets analyst Leah R. Cann maintained a Buy rating on Syros Pharmaceuticals (SYRS – Research Report) today and
Beyondspring (BYSI) Received its Third Buy in a Row
After William Blair and Robert W. Baird gave Beyondspring (NASDAQ: BYSI) a Buy rating last month, the company received another
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Qiagen (NYSE: QGEN)
Analysts fell to the sidelines weighing in on Siemens Healthineers AG (SEMHF – Research Report) and Qiagen (QGEN – Research